相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma
Jinlan He et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma
Jia Lyu et al.
CANCER BIOMARKERS (2020)
Long noncoding RNA LINC00963 promotes breast cancer progression by functioning as a molecular sponge for microRNA-625 and thereby upregulating HMGA1
Zhen Wu et al.
CELL CYCLE (2020)
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer
Martin Pichler et al.
GUT (2020)
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
Markus Krebs et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
Christopher G. Smith et al.
GENOME MEDICINE (2020)
Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
Peng Shen et al.
CELL DEATH & DISEASE (2020)
Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer
Naveen S. Vasudev et al.
BMJ OPEN (2020)
Sorting Mechanisms for MicroRNAs into Extracellular Vesicles and Their Associated Diseases
Michael Groot et al.
CELLS (2020)
SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma
Hejia Zhu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application
Jiyoon Bu et al.
BIOSENSORS & BIOELECTRONICS (2020)
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models
Mary E. Westerman et al.
BJU INTERNATIONAL (2020)
MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)
Yawen Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
lncARSR promotes liver cancer stem cells expansion via STAT3 pathway
Cheng Yang et al.
GENE (2019)
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer
Xiaohua Jiang et al.
ONCOTARGETS AND THERAPY (2019)
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
Alessia Cimadamore et al.
CANCERS (2019)
Exosomes in cancer development, metastasis, and immunity
Lin Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells
Jichun Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis
You Zhou et al.
CANCER BIOLOGY & THERAPY (2019)
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p
Lu Wang et al.
MOLECULAR CANCER (2019)
Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes
Sangiliyandi Gurunathan et al.
CELLS (2019)
Lnc-GIHCG promotes cell proliferation and migration in gastric cancer through miR- 1281 adsorption
Guozheng Liu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer
Shui-Lan Zou et al.
CANCER BIOMARKERS (2019)
Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer
Bhagyashri Kulkarni et al.
DRUG DISCOVERY TODAY (2019)
miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma
Chuanshan Zang et al.
HUMAN CELL (2019)
let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1
M-M Qin et al.
BMC UROLOGY (2019)
PVT1 Signaling Is a Mediator of Cancer Progression
Camille Derderian et al.
FRONTIERS IN ONCOLOGY (2019)
Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer
Nan Jiang et al.
CLINICA CHIMICA ACTA (2019)
SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer
Letizia Penolazzi et al.
GENE (2019)
Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL
Jinjin Sun et al.
ONCOTARGETS AND THERAPY (2019)
Long Non-Coding RNA in the Pathogenesis of Cancers
Yujing Chi et al.
CELLS (2019)
miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer
Shangwen Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p
Zhuo Ye et al.
CANCER CELL INTERNATIONAL (2019)
Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review
Yin Zhou et al.
BMJ OPEN (2019)
Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma
Dominik A. Barth et al.
CANCERS (2019)
Circulating Exosomal miR-150-5p and miR-99b-5p as Diagnostic Biomarkers for Colorectal Cancer
Ya Jing Zhao et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma
Kazutaka Okita et al.
CLINICAL GENITOURINARY CANCER (2019)
Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma
Xuegang Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
David Cella et al.
LANCET ONCOLOGY (2019)
Prognostic and Clinicopathological Significance of Long Non-coding RNA PANDAR Expression in Cancer Patients: A Meta-Analysis
Lizhi Han et al.
FRONTIERS IN ONCOLOGY (2019)
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
Daniela Schwarzenbacher et al.
BREAST CANCER RESEARCH (2019)
Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer
Xiaolian Zhang et al.
JOURNAL OF CANCER (2019)
Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
Evgeny Chirshev et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
The Role of Circulating Tumor DNA in Renal Cell Carcinoma
Paulo G. Bergerot et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
Thomas Powles et al.
EUROPEAN UROLOGY (2018)
The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities
Ivan A. Zaporozhchenko et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway
Yue Pan et al.
MOLECULAR CARCINOGENESIS (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
ARID1A loss in cancer: Towards a mechanistic understanding
Radhika Mathur
PHARMACOLOGY & THERAPEUTICS (2018)
Epidemiology and screening for renal cancer
Sabrina H. Rossi et al.
WORLD JOURNAL OF UROLOGY (2018)
Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma
Menglin Bai et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer
Xiaoxiang Chen et al.
AGING-US (2018)
MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma
Wei Zhang et al.
EUROPEAN UROLOGY FOCUS (2018)
YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma
Malin Nientiedt et al.
EUROPEAN UROLOGY FOCUS (2018)
Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
Xu Bao et al.
CANCER BIOMARKERS (2018)
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
Orietta Dalpiaz et al.
BRITISH JOURNAL OF CANCER (2017)
The Importance of Standardization on Analyzing Circulating RNA
Inyoul Lee et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late stage disease
Estelle Chanudet et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/β-catenin pathway in cervical cancer
Shengjie Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review
Lisa-Maria Schanza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway
Yaling Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores
Maximilian Seles et al.
JOURNAL OF UROLOGY (2017)
PANDAR: a pivotal cancer-related long non-coding RNA in human cancers
Jinglin Li et al.
MOLECULAR BIOSYSTEMS (2017)
miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha
Li-Li Liu et al.
MOLECULAR MEDICINE (2017)
Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN
Lingqi Liu et al.
TUMOR BIOLOGY (2017)
miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma
Ning Lou et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma
Guorong Li et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer
Siddharth Yadav et al.
UROLOGY (2017)
MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5
Yao-Jie Pan et al.
CELL DEATH & DISEASE (2017)
Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
Meijun Du et al.
ONCOTARGET (2017)
lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression
Tao Yang et al.
ONCOTARGET (2017)
Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma
Nakanori Fujii et al.
ONCOTARGET (2017)
Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
Francisca Dias et al.
ONCOTARGET (2017)
Total Extracellular Small RNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects
Ashish Yeri et al.
SCIENTIFIC REPORTS (2017)
Renal cell carcinoma: the search for a reliable biomarker
Nicholas J. Farber et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Exosome-Encapsulated microRNAs as Potential Circulating Biomarkers in Colon Cancer
Mina Hosseini et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A
Wen Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1
Mingxi Zeng et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2017)
An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma
Yi Xu et al.
BMC CANCER (2017)
Long Non-coding RNAs and their Role in Metastasis
Ulrich H. Weidle et al.
CANCER GENOMICS & PROTEOMICS (2017)
Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma
Hamulati Tusong et al.
CANCER BIOMARKERS (2017)
miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells
Xiaowen Zou et al.
MOLECULAR MEDICINE REPORTS (2016)
MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo
Qi-guang Chen et al.
TUMOR BIOLOGY (2016)
miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8
Fei Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma
Joerg Ellinger et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429
Cheng-jun Sui et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis
Tingting Huang et al.
MOLECULAR CANCER (2016)
miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B
Cheng Wang et al.
ONCOTARGET (2016)
A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
Y. Wu et al.
ONCOGENESIS (2016)
Circulating Biomarkers in Bladder Cancer
Lakshminarayanan Nandagopal et al.
BLADDER CANCER (2016)
Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma
Henriett Butz et al.
EUROPEAN UROLOGY FOCUS (2016)
External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study
Nobuyuki Tanaka et al.
EUROPEAN UROLOGY FOCUS (2016)
The Ribonuclease A Superfamily in Humans: Canonical RNases as the Buttress of Innate Immunity
Patrick Koczera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Deep sequencing reveals microRNAs predictive of antiangiogenic drug response
Jesus Garcia-Donas et al.
JCI INSIGHT (2016)
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Ariana Znaor et al.
EUROPEAN UROLOGY (2015)
The Role of Hypoxia-Induced miR-210 in Cancer Progression
Kyvan Dang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer
Yin-Jie Su et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma
Michal Fedorko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma
Vincenzo Petrozza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Jenny J. Ko et al.
LANCET ONCOLOGY (2015)
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Heba W. Z. Khella et al.
MOLECULAR THERAPY (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
miR-106a*inhibits the proliferation of renal carcinoma cells by targeting IRS-2
Yadong Ma et al.
TUMOR BIOLOGY (2015)
let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma
Jingtao Peng et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology
Bart Krist et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Circulating small non coding RNA signature in head and neck squamous cell carcinoma
Berta Victoria Martinez et al.
ONCOTARGET (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Extracellular Nucleic Acids in Urine: Sources, Structure, Diagnostic Potential
O. E. Bryzgunova et al.
ACTA NATURAE (2015)
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
Daniel Vergho et al.
BMC CANCER (2014)
MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer
Guang-jun Zhang et al.
BMC CANCER (2014)
MicroRNA expression signatures of stage, grade, and progression in clear cell RCC
Banumathy Gowrishankar et al.
CANCER BIOLOGY & THERAPY (2014)
MicroRNA-21 (miR-21) Post-Transcriptionally Downregulates Tumor Suppressor PDCD4 and Promotes Cell Transformation, Proliferation, and Metastasis in Renal Cell Carcinoma
Xiancheng Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer
John K Chan et al.
GYNECOLOGIC ONCOLOGY (2014)
Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
Hideto Iwamoto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression
Gan Yu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids
Mohammad Amin Javidi et al.
MEDICAL ONCOLOGY (2014)
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions
Lucia Vojtech et al.
NUCLEIC ACIDS RESEARCH (2014)
Identification of angiogenesis-related miRNAs in a population of patients with renal clear cell carcinoma
He-Cheng Li et al.
ONCOLOGY REPORTS (2014)
Site-Specific RNase A Activity Was Dramatically Reduced in Serum from Multiple Types of Cancer Patients
Weiyan Huang et al.
PLOS ONE (2014)
Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
Ana L. Teixeira et al.
TUMOR BIOLOGY (2014)
Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells
Mario Leonardo Squadrito et al.
CELL REPORTS (2014)
Characterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs
Jasmin Wagner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
R. I. McCormick et al.
BRITISH JOURNAL OF CANCER (2013)
Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
An Zhao et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Tackling Structures of Long Noncoding RNAs
Irina V. Novikova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma
W. -B. Zhang et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2013)
Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
Marina Colombo et al.
JOURNAL OF CELL SCIENCE (2013)
NextGen Sequencing Technology-based Dissection of Physiological Systems 5′-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma
Joseph M. Dhahbi et al.
PHYSIOLOGICAL GENOMICS (2013)
The VHL/HIF axis in clear cell renal carcinoma
Chuan Shen et al.
SEMINARS IN CANCER BIOLOGY (2013)
Differential microRNA expression in renal cell carcinoma
Tingting Cheng et al.
ONCOLOGY LETTERS (2013)
Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs
Carolina Villarroya-Beltri et al.
NATURE COMMUNICATIONS (2013)
Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma
Qingna Zhai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma
Stefan Hauser et al.
CANCER EPIDEMIOLOGY (2012)
Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma
Imke Sanders et al.
INTERNATIONAL JOURNAL OF UROLOGY (2012)
The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
Hala Faragalla et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
Martina Redova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Incidental Detection of Renal Cell Carcinoma is an Independent Prognostic Marker: Results of a Long-Term, Whole Population Study
Helga Bjork Palsdottir et al.
JOURNAL OF UROLOGY (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
Xiao-Guang Liu et al.
MEDICAL ONCOLOGY (2012)
The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
Alessia Gallo et al.
PLOS ONE (2012)
Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
Mohd Saif Zaman et al.
PLOS ONE (2012)
Comparing the MicroRNA Spectrum between Serum and Plasma
Kai Wang et al.
PLOS ONE (2012)
MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients
Angelo Gamez-Pozo et al.
NEOPLASIA (2012)
Recovering circulating extracellular or cell-free RNA from bodily fluids
Georgios Tzimagiorgis et al.
CANCER EPIDEMIOLOGY (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
Lena M. Wulfken et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Serum miRNA-21: Elevated Levels in Patients With Metastatic Hormone-Refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-Based Chemotherapy
Hai-Liang Zhang et al.
PROSTATE (2011)
miR-21 Modulates Cell Apoptosis by Targeting Multiple Genes in Renal Cell Carcinoma
Aimin Zhang et al.
UROLOGY (2011)
The VHL-dependent regulation of microRNAs in renal cancer
Calida S. Neal et al.
BMC MEDICINE (2010)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
Ceramide triggers budding of exosome vesicles into multivesicular Endosomes
Katarina Trajkovic et al.
SCIENCE (2008)
MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression
Daniel Y. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
NK Janzen et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Renal cell carcinoma: Prognostic significance of incidentally detected tumors
KH Tsui et al.
JOURNAL OF UROLOGY (2000)
分享论文
